Diet, Diabetes and Periodontitis
Control of Diabetes and Periodontitis Through a New Anti-inflammatory Nordic Diet
1 other identifier
interventional
80
1 country
1
Brief Summary
There is a significant and growing interest in nutrition and health in the general population and there is also, paradoxically, an increasing problem with obesity and general debilitating conditions of affluence, such as type 2 diabetes mellitus. Igelösa Life Science AB has developed a modified Okinawan-based Nordic Diet (OBND) diet based on evidence primarily from the diet of the long-lived and healthy Okinawa population. The diet includes fish and whole grains, with a high level of vegetables, but is low in fat. In 2016, a clinical nutrition study was carried out at Kristianstad University with the intention to determine if the OBND resulted in reductions/changes in clinical and medical markers of importance for treatment of diabetes mellitus and gingivitis/periodontitis. The diet had a positive impact on the clinical progress of otherwise debilitating conditions such as diabetes and the health benefits on clinical parameters was extremely rapid, that is, within two weeks. Not only did the patients with type 2 diabetes receive the OBND, their partners were also offered the same option. This is a key innovation and the participants stated that it was a great support, which facilitated adherence and promotes the long-term impact on health. Ingrained habits such as poor diet, can only be defeated by a concerted team effort and our work to date provides a glimpse of the potential benefits to Sweden and the rest of the developed world through this shared approach. Initial studies have shown promising effects of the OBND on both diabetes and periodontal conditions. The objective of this study is to compare the OBND to the current recommended standard diet. Assuming the study provides positive evidence of health impact due to improved food quality, it will also be seen that the production and delivery of such 'healthy-living' meals will be of commercial interest for industry. The mission is to offer an evidence-based natural food alternative that both prevents disease and improves the health status of individuals with diabetes. The long-term goal is to design efficient and effective products that will protect against diabetes and other chronic diseases. The combination of scientific credibility and commercial interests may be a key factor to transfer the new knowledge about healthy dieting into actual improvements in public health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1 diabetes-mellitus
Started Oct 2018
Typical duration for phase_1 diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 3, 2018
CompletedFirst Posted
Study publicly available on registry
January 23, 2018
CompletedStudy Start
First participant enrolled
October 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedSeptember 26, 2018
September 1, 2018
15 days
January 3, 2018
September 25, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
HbA1c
Changes in levels of HbA1c (mmol/mol) in serum before and after study procedures
Baseline, 2, 4, and 26 weeks
Secondary Outcomes (2)
Pro-inflammatory cytokines
Baseline, 2, 4, and 26 weeks
Gingivitis
Baseline, 2, 4, and 26 weeks
Study Arms (2)
Baseline
PLACEBO COMPARATORNo dietary changes.
Comparison of Diets
PLACEBO COMPARATOROkinawan-based Nordic Diet or Control Diet.
Interventions
Okinawan-based Nordic Diet and Control Diet
Eligibility Criteria
You may qualify if:
- minimum 20 teeth
- HbA1c = 60-80 mmol/mol (diabetics), HbA1c \< 42 mmol/mol (control)
- be able to receive food delivery monday, wednesday, friday
- Scandinavian background
You may not qualify if:
- use of tobacco products
- pregnancy
- lactose, celiac- or garlic intolerance
- blood pressure ≥ 180 mm Hg
- have visited dental clinic within one month Before study start or currently are undergoing dental/dental hygienist treatment
- have rheumatoid arthritis
- for Medical reasons need treatment with antibiotics or who has been treated with antiobiotics within one month before study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kristianstad
Kristianstad, Skåne County, 29188, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 3, 2018
First Posted
January 23, 2018
Study Start
October 17, 2018
Primary Completion
November 1, 2018
Study Completion
December 1, 2019
Last Updated
September 26, 2018
Record last verified: 2018-09